In a court case involving a recent product recall in Michigan, Michigan Court of Claims Judge Christopher Murray granted Viridis Laboratories a preliminary injunction for a recall of products that one of its labs tested, but denied a preliminary injunction for a recall at another of the company’s labs, according to the Detroit Free Press.
The Dec. 3 decision means that about half the recalled product will be released from recall.
The recall pertaining to products tested at Viridis Laboratories, located in Lansing, was upheld. The recall pertaining to products tested at Viridis North in Bay City was overturned. Both labs share ownership but are separate LLCs, according to the Detroit Free Press.
The Marijuana Regulatory Agency (MRA) issued a bulletin on Dec. 3 stating that the recall on Viridis North products had been enjoined and that the agency “will release the administrative holds on all products” that were recalled after the lab tested them.
Previously, the MRA cited in its original Nov. 17 recall notice that consumers of the recalled products who have lung diseases or weakened immune systems are at the highest risk of developing aspergillosis.
In their lawsuit, the labs contended that the agency had targeted Viridis—which by its own estimation tests between 60 and 70% of Michigan’s cannabis products—to point cannabis businesses to work with other testing labs, according to the Detroit Free-Press.
“While we maintain that the entire recall was completely without merit, we applaud the court for at least reversing the MRA’s faulty decision to recall products tested at Viridis Bay City,” Kevin Blair, an attorney with Honigman LLP, said in an emailed statement also obtained by other media.